Ebtisam Taha Badawy

Mrs. Ebtisam Taha Badawy

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ARAmany E Ragab
Amany E Ragab
EBEbtisam Taha Badawy
Ebtisam Taha Badawy
SAShaimaa M Aboukhatwa
Shaimaa M Aboukhatwa
AKAmal Kabbash
Amal Kabbash
KEKamilia A. Abo El-Seoud
Kamilia A. Abo El-Seoud
The search for anticancer drugs is of continuous interest. Arecoline is an alkaloid with anticancer activity. Herein, the metabolism of arecoline through fungal transformation was investigated for the discovery of potential anticancer drugs with higher activity and selectivity. Compounds 1–5 were isolated, and their structures were fully elucidated using various spectroscopic analyses, including 1D and 2D NMR, ESIMS, and HRESIMS. This is the first report for the isolation of compounds 1 and 2. An MTT assay was performed to determine the cytotoxic activity of arecoline and its metabolites in vitro using non-small-cell lung cancer A549 and leukemia K562 cell lines compared to staurosporine and doxorubicin as positive controls. For the non-small-cell lung A549 cell line, arecoline hydrobromide, staurosporine, and doxorubicin resulted in IC50 values of 11.73 ± 0.71 µM, 10.47 ± 0.64 µM, and 5.05 ± 0.13 µM, respectively, while compounds 1, 3, and 5 exhibited IC50 values of 3.08 ± 0.19 µM, 7.33 ± 0.45 µM, and 3.29 ± 0.20 µM, respectively. For the leukemia K562 cell line, the IC50 values of arecoline hydrobromide, staurosporine, and doxorubicin were 15.3 ± 1.08 µM, 5.07 ± 0.36 µM, and 6.94 ± 0.21 µM, respectively, while the IC50 values of compounds 1, 3 and 5 were 1.56 ± 0.11 µM, 3.33 ± 0.24 µM, and 2.15 ± 0.15 µM, respectively. The selectivity index value of these compounds was higher than 3. These results indicated that compounds 1, 3, and 5 are very strong cytotoxic agents with higher activity than the positive controls and good selectivity toward the tested cancer cell lines. Cell cycle arrest was then studied by flow cytometry to investigate the apoptotic mechanism. Docking simulation revealed that most compounds possessed good binding poses and favorable protein-ligand interactions with muscarinic acetylcholine receptor M3-mAChR protein. In silico study of pharmacokinetics using SwissADME predicted compounds 1–5 to be drug-like with a high probability of good oral bioavailability.

10 May 2023 in Journal of Advanced Medical and Pharmaceutical Research
Verified
Journal Article
Closed access
EBEbtisam Taha Badawy
Ebtisam Taha Badawy
KAKamelia A. Abouelsaoud
Kamelia A. Abouelsaoud
AKAmal Kabbash
Amal Kabbash
ARAmany Ragab
Amany Ragab
Isoniazid is a synthetic antimicrobial and one of the most essential first-line drugs used in the treatment of tuberculosis. In addition, isoniazid has been used as a prophylactic drug for patients with latent Mycobacterium tuberculosis infection to prevent reactivation of disease. It is a prodrug which activated by catalase peroxidase (KatG) enzyme. Catalase peroxidase enzyme converts isoniazid to reactive species. Isoniazid reactive species inhibit enoyl acyl-carrier protein reductase (InhA) enzyme which involved in the biosynthesis of fatty acids of mycobacteria. Isoniazid is metabolized by amidase enzyme into isonicotinic acid and hydrazine. Chronic toxicity of isoniazid results in hepatotoxicity and peripheral neuropathy. For active tuberculosis, isoniazid is often used together with rifampicin, pyrazinamide and either streptomycin or ethambutol. Multiple, extensively and totally drug resistant strains of Mycobacterium tuberculosis were reported. Due to the development of Mycobacterium tuberculosis resistance to isoniazid, a continuous search for new drugs is a demand to combat this global problem.

10 May 2023 in Journal of Advanced Medical and Pharmaceutical Research
Verified
Journal Article
Closed access
EBEbtisam Taha Badawy
Ebtisam Taha Badawy
KAKamelia A. Abouelsaoud
Kamelia A. Abouelsaoud
ARAmany Ragab
Amany Ragab
AKAmal Kabbash
Amal Kabbash
Arecoline is a psychoactive alkaloid containing reduced pyridine nucleus, isolated from Areca catechu L. (Arecaceae) with different biological activities on cardiovascular, digestive, nervous and endocrine systems. Arecoline is the main toxic component of A. catechu responsible for oral carcinoma. It possesses a variety of pharmacological activities; it exhibits anticancer activity. It was reported that arecoline causes cytotoxicity through apoptosis in human endothelial cells. Moreover, death of human leukemia K562 cells was induced by arecoline. Biotransformation is a structural modification of compounds such as amino acids, toxins and drugs by enzymatic chemical reactions within the living organisms. According to enzymatic sources, biotransformation is classified into three major types; microbial, plant cell culture and animal cell culture transformation. It was suggested that microorganisms could be employed as a model of mammalian metabolism. Studying both mammalian and microbial transformation of arecoline is of interest by which we can reduce its toxicity, increase its bioavailability and to produce more active metabolites.

1 January 2026 in RSC Advances
Verified
Journal Article
Open access
EBEbtisam Taha Badawy
Ebtisam Taha Badawy
ARAmany E Ragab
Amany E Ragab
Mohamed FaragMohamed Farag
Mohamed Farag
DFDoris Finkelmeier
Doris Finkelmeier
ABAnke Burger-Kentischer
Anke Burger-Kentischer
Ahmed ZayedAhmed Zayed
Ahmed Zayed
Marine macroalgae-associated fungi constitute an underexplored reservoir of structurally diverse secondary metabolites with considerable pharmaceutical potential.